Extension of human GCSF serum half-life by the fusion of albumin binding domain

Abstract Granulocyte colony stimulating factor (GCSF) can decrease mortality of patients undergo chemotherapy through increasing neutrophil counts. Many strategies have been developed to improve its blood circulating time. Albumin binding domain (ABD) was genetically fused to N-terminal end of GCSF...

Deskribapen osoa

Gorde:

Xehetasun bibliografikoak
Egile Nagusiak:	Fatemeh Yadavar Nikravesh, Samira Shirkhani, Elham Bayat, Yeganeh Talebkhan, Esmat Mirabzadeh, Masoumeh Sabzalinejad, Hooman Aghamirza Moghim Aliabadi, Leila Nematollahi, Yalda Hosseinzadeh Ardakani, Soroush Sardari
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Nature Portfolio 2022-01-01
Saila:	Scientific Reports
Sarrera elektronikoa:	https://doi.org/10.1038/s41598-021-04560-6
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Extension of human GCSF serum half-life by the fusion of albumin binding domain

Antzeko izenburuak